LYFIX Mutual Fund
LYFIX Mutual Fund
LYFIX Mutual Fund
AlphaCentric Life Sciences and Healthcare Fund Class I
LYFIX Mutual Fund Overview
LYFIX Mutual Fund (AlphaCentric Life Sciences and Healthcare Fund Class I) is managed by Alpha Centric Fund with $39.9M in net assets. LYFIX expense ratio is 1.46%, holding 63 positions across sectors including Health Care, Financials. Inception date: 2019-11-29.
LYFIX performance shows a YTD return of 13.54%. The 1-year return is 51.04% and the 5-year return is 10.11%. LYFIX dividend yield stands at 1.58%, paid annually.
LYFIX top holdings include First Am Treas Obli-X (7.7%), Gilead Sciences (7.2%), Astrazeneca Plc (5.6%), Nvaesrtex Pharmaceuticals Inc (5.6%), Ionis Pharmaceuticals Inc (3.7%). Go to all LYFIX holdings, LYFIX sectors, or LYFIX dividends.
LYFIX can be compared against other funds. Use LYFIX overlap to find shared positions, or LYFIX vs another fund for a side-by-side view. LYFIX alternatives are available via the screener, along with tax-loss harvesting opportunities.